Diferencia entre revisiones de «Dapsone»

Revisión actual - 11:08 20 mar 2026

Disease	Dose	Context
Bullous pemphigoid	50mg PO QD; Use with topical or systemic corticosteroids	Bullous pemphigoid
Dermatitis herpetiformis	50mg PO QD	Dermatitis herpetiformis
Leprosy	paucibacillary: 100mg PO QD x6mo; Use with rifampin; multibacillary: 100mg PO QD x12mo; Use with rifampin, clofazimine	Hansen's disease (leprosy)
Malaria	100mg PO weekly	Suppression
Pneumocystis jirovecii pneumonia	100mg PO once daily	Mild disease with TMP
Toxoplasmosis	50mg PO QD; Off label use	Toxoplasmosis prophylaxis

Disease	Dose	Context
Pneumocystis jirovecii pneumonia	2mg/kg/day PO (max 100mg)	Pediatric Mild
Pneumocystis jirovecii pneumonia	2mg/kg/day PO daily (max 100mg)	Pediatric Prophylaxis alt

Authors:

@@ Línea 5: / Línea 5: @@
 ==Adult Dosing==
-===[[Hansen's disease]] ([[leprosy]])===
-*paucibacillary: 100mg PO QD x6mo
-**Use with rifampin
-*multibacillary: 100mg PO QD x12mo
-**Use with rifampin, clofazimine
-===[[Bullous pemphigoid]]===
-*50mg PO QD
-**Use with topical or systemic [[corticosteroids]]
-===Dermatitis herpetiformis===
-*50mg PO QD
-===[[Pneumocystis jirovecii pneumonia|PCP]]===
-*Prophylaxis: 100mg/day PO divided QD-bid
-**Off label use
-*Treatment: 100mg PO QD x21 days
-**Not 1st-line agent; use with [[trimethoprim]]
-**Off label use
-===[[Malaria]] suppression===
-*100mg PO qwk
-**Use with [[pyrimethamine]]
-**Off label use
-===[[Toxoplasmosis]] prophylaxis===
-*50mg PO QD
+===Indications by Disease===
-**Off label use
+{{#ask: [[Has DrugName::Dapsone]] [[Has Population::Adult]]
+ |?Treats disease=Disease
+ |?Has Dose=Dose
+ |?Has Context=Context
+ |format=table
+ |limit=50
+ |mainlabel=-
+ |headers=show
+ |sort=Treats disease
+}}
 ==Pediatric Dosing==
+===Indications by Disease===
+{{#ask: [[Has DrugName::Dapsone]] [[Has Population::Pediatric]]
+ |?Treats disease=Disease
+ |?Has Dose=Dose
+ |?Has Context=Context
+ |format=table
+ |limit=50
+ |mainlabel=-
+ |headers=show
+ |sort=Treats disease
+}}
 ==Special Populations==